Faculty News

Elaine S. Jaffe receives HHS Career Achievement Award

Elaine S. Jaffe, M.D., NIH Distinguished Investigator in the Laboratory of Pathology, was awarded a 2022 Career Achievement Award by the Department of Health and Human Services in recognition of her groundbreaking advances in the diagnosis and treatment of patients with blood cancers.

Kandice Tanner receives Arthur S. Flemming Award

Kandice Tanner, Ph.D., a Senior Investigator in the Laboratory of Cell Biology, is a recipient of the 2021 Arthur S. Flemming Awards, which honor the accomplishments of midcareer federal employees. Dr. Tanner received the award for her breakthrough discovery that patterns of cancer spread in humans can be recreated in zebrafish. This novel animal model allows researchers to address organ-specific drug responses and develop effective immunotherapies in a preclinical platform.

CCR scientists to present at 2022 AACR Annual Meeting in New Orleans

The American Association for Cancer Research (AACR) Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. Several CCR scientists will present their research at the AACR Annual Meeting.

Steven Pavletic named Top Ten Clinical Research Achievement awardee

Steven Z. Pavletic, M.D., M.S., Senior Clinician in the Immune Deficiency Cellular Therapy Program, has been named a Top Ten Clinical Research Achievement awardee by the Clinical Research Forum for his study “A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.”

Anish Thomas explains the challenges and goals of his small cell lung cancer research

Anish Thomas, M.B.B.S., M.D., Lasker Clinical Research Scholar in the Developmental Therapeutics Branch, studies small cell lung cancer (SCLC). For Lung Cancer Awareness Month, Thomas describes his current research interests and his goals to help improve the lives of patients with SCLC – the most lethal type of lung cancer.

Rosenberg, Waldmann named 2021 Fellows of the Academy of Immuno-Oncology

Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, and Thomas A. Waldmann, M.D., Chief Emeritus of the Lymphoid Malignancies Branch (honored posthumously), have been named 2021 Fellows of the Academy of Immuno-Oncology, one of the most prestigious honors from the Society for Immunotherapy of Cancer (SITC). The Academy of Immuno-Oncology was established to honor individuals who have launched the field of cancer immunotherapy into the breakthrough cancer treatment it is today and to bring together the brightest minds in the field to continue to advance SITC, the field and the next generation of immuno-oncologists.

A conversation with Hunter Lab members about the Deaf Student Training Program

Kent W. Hunter, Ph.D., Senior Investigator in the Laboratory of Cancer Biology and Genetics, leads the Deaf Student Training Program (DSTP) for budding scientists who are deaf or hard-of-hearing. In honor of National Disability Employment Awareness Month, DSTP participants talk about their experiences in the program, and Dr. Hunter offers his thoughts as a cancer researcher and disability ally.

In Memoriam: Thomas A. Waldmann, M.D. (1930-2021)

The CCR mourns the recent passing of longtime colleague and friend, Thomas A. Waldmann, M.D., Chief Emeritus of the Lymphoid Malignancies Branch, NIH Distinguished Investigator and immunology pioneer.

Sandra L. Wolin receives Sandra K. Masur Senior Leadership Award

Sandra L. Wolin, M.D., Ph.D., Chief of the RNA Biology Laboratory, is the 2021 recipient of the Sandra K. Masur Senior Leadership Award from the American Society for Cell Biology. This award is in recognition of a scientist whose outstanding scientific achievements are coupled with a record of active leadership in mentoring women and individuals from underrepresented groups in their scientific careers.

Samira M. Sadowski discusses her work at CCR and offers advice for future cancer researchers

Samira M. Sadowski, M.D., is a Physician-Scientist Early Investigator in the Surgical Oncology Program. Along with her role as a surgeon, she studies rare forms of thyroid cancer as well as neuroendocrine tumors of the pancreas and gastrointestinal tract. In this Q&A, she talks about her current research interests and offers advice for future cancer researchers.

Breadcrumb